The Company granted stock awards in the form of RSUs, cash-settled RSUs, and performance shares to employees and non-employee directors under the 2018 Amended and Restated Omnibus Plan (the “2018 A&R Omnibus Plan”). On June 2, 2026, the Company’s stockholders approved the 2026 Omnibus Incentive Plan (the “2026 Omnibus Plan”) that replaced the 2018 A&R Omnibus Plan. As of June 30, 2026, 473,743 shares previously awarded under the 2018 A&R Omnibus Plan remained outstanding.

The 2026 Omnibus Plan allows the Company to grant up to 1,321,000 total shares of common stock to officers, key employees, and non-employee directors. As of June 30, 2026, the Company had 1,319,931 shares available for grant under the 2026 Omnibus Plan.

The following awards were granted during the three and six months ended June 30, 2026 and 2025:


	Awards Granted				Average Grant Date Fair Value				Awards Granted				Average Grant Date Fair Value
	Three Months Ended				Three Months Ended				Six Months Ended				Six Months Ended
	June 30,				June 30,				June 30,				June 30,
	2026		2025		2026		2025		2026		2025		2026		2025
Employee Stock Awards - RSUs		1,069		134	$	64.36	$	84.46		133,060		142,855	$	65.88	$	84.83
Employee Stock Awards - PSAs		—		—	$	—	$	—		70,836		75,313	$	66.40	$	76.42
Cash-Settled RSUs		1,355		343	$	64.36	$	84.46		69,968		73,421	$	65.86	$	84.83
Non-Employee Director Stock Awards - RSUs		—		444	$	—	$	84.40		—		444	$	—	$	84.40
Total		2,424		921						273,864		292,033

The total stock-based compensation expense was $5.5 million and $5.8 million for the three months ended June 30, 2026 and 2025, respectively, and $10.9 million and $9.8 million for the six months ended June 30, 2026 and 2025, respectively. The unrecognized compensation expense at June 30, 2026 was $31.9 million, which is expected to vest over the next 1.9 years.